Psychatic disorders associated with retinitis pigmentosa: a two cases report

##plugins.themes.academic_pro.article.sidebar##

Published Apr 5, 2010
Download
pdf
Vol. 88 No. 4 (2010): Issue Apr 2010

##plugins.themes.academic_pro.article.main##

Mehdi Boutheina
Boutheina Mehdi
Anwar Mechri
Leila Gassab
Salim Ben Yahia
Moncef Khiarallah
Lotfi Gaha

##plugins.themes.academic_pro.article.details##

References

  1. Berson EL, Rosner B, Sandberg MA et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophtalmol 2004;122:1306-14.
  2. Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. J Clin Pharm Ther 2002;27:161-8.
  3. Daghfous MT, Ayed S, Ben Nejma L. Heredity in pigmented retinopathy. Tunis Med 1987;65:133-5.
  4. Fain GL, Lisman JE. Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis. Exp Eye Res 1993;57:335-40.
  5. Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 1998;95:7240-4.
  6. Goodman AB. Chromosomal locations and modes of action of genes of the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia. Am J Med Genet 1995;60:335-48.
  7. Hess-Röver J, Crichton J, Byrne K, Holland AJ. Diagnosis and treatment of a severe psychotic illness in a man with dual severe sensory impairments caused by the presence of Usher syndrome. J Intellect Disabil Res 1999;43:428-34.